Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Champions Oncolog (CSBR)

Champions Oncolog (CSBR)
8.01 +0.39 (+5.19%) 13:44 ET [NASDAQ]
7.88 x 100 7.99 x 100
Realtime by (Cboe BZX)
7.88 x 100 7.99 x 100
Realtime - - (-) -
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Champions Oncolog One University Plaza Suite 307 Hackensack NJ 07601 USA

www.championsoncology.com Employees: 210 P: 201-808-8400

Sector:

Medical

Description:

Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 105,223
Enterprise Value, $K 102,603
Shares Outstanding, K 13,827
Annual Sales, $ 50,160 K
Annual Net Income, $ -7,280 K
Last Quarter Sales, $ 17,040 K
Last Quarter Net Income, $ 4,500 K
EBIT, $ 6,720 K
EBITDA, $ 8,590 K
60-Month Beta 0.46
% of Insider Shareholders 46.98%
% of Institutional Shareholders 41.30%
Float, K 7,331
% Float 53.02%
Short Volume Ratio 0.41

Growth:

1-Year Return 58.20%
3-Year Return -0.91%
5-Year Return -0.52%
5-Year Revenue Growth 85.30%
5-Year Earnings Growth -5,500.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.31 on 03/11/25
Next Earnings Date N/A
Earnings Per Share ttm 0.44
EPS Growth vs. Prev Qtr 520.00%
EPS Growth vs. Prev Year 263.16%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/12/15

CSBR Ratios

Ratio
Price/Earnings ttm 17.89
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 656.65%
Return-on-Assets % 24.04%
Profit Margin % -14.51%
Debt/Equity 0.00
Price/Sales 2.17
Price/Cash Flow N/A
Price/Book 19.89
Book Value/Share 0.40
Interest Coverage -0.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective